GlobeNewswire by notified

Cavotec wins breakthrough clean-tech order for industrial battery charging worth over EUR 3M

Share

In a major development signalling Cavotec’s entry into industrial battery charging for heavy duty vehicles, Cavotec is to supply a proof-of-concept battery charging system for use with heavy-duty mining trucks. The value of this first order is over EUR 3M with a potential for follow up orders, opening up a market that is estimated to be worth several hundred million euros in the coming years. Delivery is scheduled for the beginning of 2023.

Building on Cavotec’s experience with fast, high power charging for marine applications and working closely with the customer – a leading green energy technology company – Cavotec will develop a solution to serve as a proof-of-concept for high-voltage charging of electrically-powered heavy-duty vehicles at a mining application in Australia. 

This important project highlights how Cavotec is leading the development of large scale industrial battery charging solutions and technologies that will enable industries to decarbonise and reduce their environmental impact.

“This key order highlights how Cavotec’s clean tech expertise is enabling its customers to achieve profitable sustainability by providing the tools for electrification of heavy duty equipment, a market that is set for considerable growth in the years ahead,” says Mikael Norin, CEO of Cavotec. “I’m pleased that the considerable investments we have made in technology and capabilities in the last year since announcing our strategy to focus on clean-tech for marine and industrial applications are starting to pay off”, continued Norin.

For further details on this release, please contact:

Johan Hähnel
Investor Relations Manager
+46 70 605 63 34; investor@cavotec.com

This information was submitted for publication, through the agency of the contact person set out above, at 08:30 CEST on 25 April 2022.

About Cavotec
Cavotec is a leading cleantech company that designs and delivers connection and electrification solutions to enable the decarbonisation of ports and industrial applications. Backed by more than 40 years of experience, our systems ensure safe, efficient and sustainable operations for a wide variety of customers and applications worldwide. Learn more at cavotec.com.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Sweegen Wins Stevia Reb M Patent Lawsuit Against PureCircle24.5.2022 11:04:00 CEST | Press release

Rancho Santa Margarita, Calif., May 24, 2022 (GLOBE NEWSWIRE) -- Sweegen, the global pioneer in wellness ingredient technologies and innovations, announced its victory against PureCircle in a stevia Rebaudioside M (Reb M) patent lawsuit. "Today's judgment vindicates Sweegen and affirms the company's position as an industry leader in innovative sweetener solutions," said Steven Chen, CEO of Sweegen. PureCircle, acquired by Ingredion in 2020, had filed the 2018 lawsuit against Sweegen in the U.S. District Court for the Central District of California, accusing Sweegen of infringing two PureCircle patents covering the manufacture of Reb M. The legal tide turned on PureCircle when Sweegen obtained a summary judgment that both of PureCircle's asserted patents are invalid. Since it is impossible to infringe an invalid patent, the court's invalidation of the asserted patents ends the infringement case against Sweegen at the U.S. District Court. "As a holder of core proprietary technologies of

Notification and Public Disclosure of Transactions by Person Discharging Managerial Responsibilities24.5.2022 11:00:00 CEST | Press release

Company Announcement No. 38/2022 Copenhagen, 24 May 2022 Notification and Public Disclosure of Transactions by Person Discharging Managerial Responsibilities 1. Information on the person discharging managerial responsibilities/person closely associated a) Name Anders Obel 2. Reason for the notification a) Position/title Member of the Board of Directors b) Initial notification/amendment Initial notification 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Scandinavian Tobacco Group A/S b) LEI code 5299003KG4JS99TRML67 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of instrument Identification code Shares DK0060696300 – STG b) Nature of the transaction Sale of shares c) Price(s) and volume(s) Price(s)Volume(s)DKK 147.6 7,

Disclosure of voting rights for Chairman of the Board24.5.2022 10:44:47 CEST | Press release

Oslo, 24 May 2022. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of its chairman, Hans Peter Bøhn. Hans Peter Bøhn is chairman of PCI Biotech and shall open the annual general meeting of the Company on 25 May 2022. Mr. Bøhn holds 123,662 shares, representing 0.3 per cent of the share capital of PCI Biotech. Mr. Bøhn has received powers of attorney to represent and vote for 7,234,249 additional shares. In total, Mr. Bøhn will represent and vote for 19.7 per cent of the share capital. A major part of the powers of attorney are without voting instructions. The powers of attorney are only valid at the annual general meeting on 25 May 2022. This information is subject to the disclosure requirements pursuant to section 4 -3, cf. section 5-12 of the Norwegian Securities Trading Act. Contact information: PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo Ronny Skuggedal, CFO, rs@pcibiotech.no, Mobile: +47 9400 5757

PRESS RELEASE: NQX has been certified by NCSA-FI for security level TL III24.5.2022 10:15:00 CEST | Press release

NQX has been certified by NCSA-FI for security level TL III SSH announced today that it has received a TL III-level security certification for its NQX quantum line encryption software version 2.2 from the Finnish National Cyber Security Center (NCSA). The certification enables the solution to be used to secure networks requiring TL III level encryption for the transmission of confidential and sensitive information. The certified NQX 2.2 includes central management functionality that enables convenient remote management of network nodes. NQX central manager simplifies and automates the management and maintenance of Public Key Infrastructures (PKI) and certifications of nodes and connections regardless of their location. Because of its intuitive user interface, NQX central manager is easy to use and administrators can perform critical management tasks with minimal human effort. NQX's capability to support various network deployment approaches is enhanced with an isolated management chann